Rhythm Biosciences Ltd (RHY) Company Profile

Rhythm Biosciences Ltd Company Snapshot

Rhythm Biosciences Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Rhythm Biosciences Ltd with three other pharmaceutical manufacturers in Australasia: Prescient Therapeutics Ltd (2021 sales of 66,285.00 Australian Dollars [US$48,312.49 ] of which 100% was Clinical stage oncology), Alterity Therapeutics Ltd (20,676.00 Australian Dollars [US$15,069.91 ] of which 100% was Reaserch and development in the field of), and Genetic Technologies Limited (120,554.00 Australian Dollars [US$87,866.99 ] ).

Sales Analysis.

Rhythm Biosciences Ltd

Stock Data:

Recent Stock Performance:

Current Price (9/17/2021): 1.13
(Figures in Australian Dollars)

1 Week	4.7%	13 Weeks	22.3%

4 Weeks	18.7%	52 Weeks	544.6%

Rhythm Biosciences Ltd Key Data:

Ticker:	RHY	Country:	Australia

Exchanges:	ASX	Major Industry:	Pharmaceuticals & Biotechnology

		Sub Industry:	Pharmaceutical Preparations

2021 Sales	13,973 (Year Ending Jan 2022).	Employees:	N/A

Currency:	Australian Dollars	Market Cap:	228,057,919

Fiscal Yr Ends:	June	Shares Outstanding:	202,718,150

Share Type:	Ordinary	Closely Held Shares:	80,856,355

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.